Low-dose Computed Tomography Lung Cancer Screening Participants Show Improved 10-year Survival Compared With Matched...

Area of Science:

• Pulmonary Medicine
• Oncology
• Epidemiology

Background:

• Lung cancer remains a leading cause of cancer mortality globally.
• Early detection through screening can significantly improve patient outcomes.
• Low-dose computed tomography (LDCT) is a promising tool for lung cancer screening.

Purpose of the Study:

• To evaluate the prevalence of comorbidities in a Polish population undergoing LDCT screening.
• To compare 10-year overall survival between an LDCT-screened population and a matched general population.
• To identify factors associated with improved survival in the screened cohort.

Main Methods:

• Observational case-control study involving 43,686 participants aged 50-75 years with at least 10 years of follow-up.
• Screening group (n=7281) underwent LDCT between 2009-2011.
• Control group (n=36,405) matched from the general Polish population using 32 variables.

Main Results:

• Common comorbidities included hypertension (52.2%), chronic coronary artery disease (20.5%), hypercholesterolemia (13.2%), and diabetes (13.0%).
• LDCT screening was associated with improved survival (HR=0.653).
• The 10-year overall survival was 86.9% in the screening group versus 81.3% in the control group (p<0.001).

Conclusions:

• Participation in LDCT lung cancer screening is linked to enhanced 10-year overall survival in adults aged 50-75.
• Findings support LDCT utilization for high-risk individuals.
• Further prospective research is needed to understand the underlying survival mechanisms.